TY  - CONF
AU  - Menjón-Beltrán, S
AU  - Olivencia-Dueso, R
AU  - González-Jiménez, E
AU  - Titos, MJ
PY  - 2007
DO  - 10.1186/bcr1717
SN  - 1465-5411
UR  - http://hdl.handle.net/10668/556
T2  - Breast Cancer Research
AB  - Trastuzumab and gemcitabine are two active drugs for meta-static breast cancer (MBC) treatment. We conducted a retrospective study of this combination in patients with Her2+ MBC in our hospital.
LA  - en
PB  - BioMed Central
KW  - Anticuerpos Monoclonales Humanizados
KW  - Antineoplásicos
KW  - Neoplasias de la Mama
KW  - Metástasis de la Neoplasia
KW  - Antimetabolitos Antineoplásicos
KW  - Femenino
KW  - Humanos
KW  - Receptor erbB-2
KW  - Medical Subject Headings::Chemicals and Drugs::Amino Acids, Peptides, and Proteins::Proteins::Blood Proteins::Immunoproteins::Immunoglobulins::Antibodies::Antibodies, Monoclonal::Antibodies, Monoclonal, Humanized
KW  - Medical Subject Headings::Chemicals and Drugs::Chemical Actions and Uses::Pharmacologic Actions::Therapeutic Uses::Antineoplastic Agents
KW  - Medical Subject Headings::Diseases::Neoplasms::Neoplasms by Site::Breast Neoplasms
KW  - Medical Subject Headings::Diseases::Neoplasms::Neoplastic Processes::Neoplasm Metastasis
KW  - Medical Subject Headings::Chemicals and Drugs::Chemical Actions and Uses::Pharmacologic Actions::Molecular Mechanisms of Pharmacological Action::Antimetabolites::Antimetabolites, Antineoplastic
KW  - Medical Subject Headings::Check Tags::Female
KW  - Medical Subject Headings::Organisms::Eukaryota::Animals::Chordata::Vertebrates::Mammals::Primates::Haplorhini::Catarrhini::Hominidae::Humans
KW  - Medical Subject Headings::Chemicals and Drugs::Enzymes and Coenzymes::Enzymes::Transferases::Phosphotransferases::Phosphotransferases (Alcohol Group Acceptor)::Protein Kinases::Protein-Tyrosine Kinases::Receptor Protein-Tyrosine Kinases::Receptor, erbB-2
TI  - Study of the combination gemcitabine and trastuzumab in the treatment of HER2+ metastatic breast cancer
TY  - conference poster
ER  -